Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Eris Lifesciences Ltd.
NSE: ERIS
|
BSE: 540596
|
ISIN: INE406M01024
|
Industry: Pharmaceuticals
Results
|
Turnaround Potential
1808.4000
9.50
(
0.53
%)
NSE
Aug 01, 2025
15:31 PM
72.06% Gain from 52W Low
Volume:
96,925
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Eris Lifesciences Ltd.
18 May 2023
Results
1808.40
0.53%
Eris Lifesciences (BUY): Integration costs weigh on quarter
Buy:
Eris Lifesciences Ltd.
by
BOB Capital Markets Ltd.
Target: 800
Target
BOB Capital Markets Ltd.
Consolidated Q4 revenue/EBITDA growth of 32%/23% YoY missed consensus by 3%/10%
Eris Lifesciences Ltd. has gained
45.90%
in the last 6 Months
More from Eris Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - August 1, 2025
The Baseline |
01 Aug 2025, 05:05PM
Market closes lower, Godrej Properties' revenue beats Forecaster estimates by 40% in Q1
Trendlyne Marketwatch |
01 Aug 2025, 03:57PM
Earnings Call Transcript - Q1FY21 for Eris Lifesciences
|
04 Aug 2020